Crossmark

BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant

Published Online: 2022-02-22

Authors

Knabl, Ludwig

Lee, Hye Kyung

Wieser, Manuel

Mur, Anna

Zabernigg, August

Knabl, Ludwig Sr.

Rauch, Simon http://orcid.org/0000-0002-3264-6303
Bock, Matthias

Schumacher, Jana

Kaiser, Norbert

Furth, Priscilla A. http://orcid.org/0000-0003-3883-0715
Hennighausen, Lothar http://orcid.org/0000-0001-8319-9841
Funding

Funding for this research was provided by:

NIDDK IRP
License Information

Text and Data Mining valid from 2022-02-22

Version of Record valid from 2022-02-22
More Information

Article History

Received: 9 May 2021

Accepted: 1 February 2022

First Online: 22 February 2022

Competing interests

: The authors declare no competing interests.

Document is current